Crystal structure of Mycobacterium tuberculosis ClpP1P2 suggests a model for peptidase activation by AAA+ partner

Karl R Schmitz1, Daniel W Carney2, Jason K Sello2

  • 1Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; and.

Insights

Mycobacterium tuberculosis ClpP1P2 proteases require activators to form functional complexes. Cyclic acyldepsipeptides (ADEPs) and agonist peptides synergistically activate ClpP1P2, mimicking AAA+ partners and substrates for protein degradation.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • Caseinolytic peptidase P (ClpP) is a crucial protease involved in ATP-dependent protein degradation.
  • Unlike many ClpP enzymes, Mycobacterium tuberculosis ClpP1P2 forms discrete heptamers requiring partners for activation.

Purpose of the Study:

  • To elucidate the mechanism of activation and structure of the Mycobacterium tuberculosis ClpP1P2 protease complex.
  • To investigate the synergistic activation by cyclic acyldepsipeptides (ADEPs) and agonist peptides.

Main Methods:

  • X-ray crystallography to determine the structure of the activated ClpP1P2 complex.
  • Biochemical assays to study enzyme activity and activation mechanisms.

Main Results:

  • ADEPs and agonist peptides synergistically activate ClpP1P2 by mimicking AAA+ partners and substrates.
  • The structure of the activated ClpP1P2 complex reveals tight coupling between the conformations of the two rings.
  • ADEPs bind to one ring but influence the axial pore opening of both rings.

Conclusions:

  • This study establishes the basis for heteromeric ClpP1P2 assembly and function.
  • The findings provide a foundation for developing novel drugs targeting Clp-family proteolysis.
  • Insights into ClpP1 and ClpP2 ring roles in proteolysis are suggested.

Related Concept Videos